|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
4
|
|
pubmed:dateCreated |
2003-4-14
|
|
pubmed:abstractText |
Chordomas of the skull base are generally regarded as slow-growing tumors; however, approximately 20% of these lesions have been shown to recur as early as 1 year postsurgery. The classic pathological paradigms are poor predictors of outcome, and additional markers are needed to identify patients at risk for early tumor recurrence. In this study the authors describe such a marker.
|
|
pubmed:commentsCorrections |
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
AIM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Apr
|
|
pubmed:issn |
0022-3085
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
98
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
812-22
|
|
pubmed:dateRevised |
2008-7-10
|
|
pubmed:meshHeading |
pubmed-meshheading:12691407-Adult,
pubmed-meshheading:12691407-Aged,
pubmed-meshheading:12691407-Aged, 80 and over,
pubmed-meshheading:12691407-Chordoma,
pubmed-meshheading:12691407-DNA-Binding Proteins,
pubmed-meshheading:12691407-Female,
pubmed-meshheading:12691407-Genes, p53,
pubmed-meshheading:12691407-Humans,
pubmed-meshheading:12691407-Male,
pubmed-meshheading:12691407-Middle Aged,
pubmed-meshheading:12691407-Neoplasm Recurrence, Local,
pubmed-meshheading:12691407-Prognosis,
pubmed-meshheading:12691407-RNA, Messenger,
pubmed-meshheading:12691407-Skull Base Neoplasms,
pubmed-meshheading:12691407-Telomerase
|
|
pubmed:year |
2003
|
|
pubmed:articleTitle |
Chordoma of the skull base: predictors of tumor recurrence.
|
|
pubmed:affiliation |
Institute of Neurosurgery, Departmnet of Neurosurgery, Catholic University School of Medicine, Rome, Italy. pallini@rm.unicatt.it
|
|
pubmed:publicationType |
Journal Article
|
